All patients (n = 245) | Stage G1-G2 CKD (n = 131) | Stage G3-G4 CKD (n = 114) | P | |
---|---|---|---|---|
Age (years) | 64.6 ± 10.5 | 61.6 ± 11.0 | 68.0 ± 8.9 | <0.001 |
Gender (% male) | 82.9 | 81.7 | 84.2 | 0.60 |
Height (m) | 1.6 ± 0.1 | 1.64 ± 0.08 | 1.62 ± 0.08 | 0.13 |
Weight (kg) | 63.3 ± 11.5 | 63.7 ± 12.2 | 63.0 ± 10.6 | 0.64 |
Body mass index (kg/m2) | 23.8 ± 3.3 | 23.7 ± 3.4 | 23.9 ± 3.1 | 0.54 |
Unemployed (%) | 50.2 | 40.5 | 60.5 | 0.002 |
Intervention for IHD | 0.79 | |||
CABG (%) | 22.0 | 21.4 | 22.8 | |
PCI (%) | 78.0 | 78.6 | 77.2 | |
Comorbidities (%) | ||||
Cerebrovascular disease | 8.6 | 6.9 | 10.5 | 0.31 |
Orthopedic disorder | 17.6 | 19.1 | 15.8 | 0.50 |
Diabetes mellitus | 39.6 | 34.4 | 45.6 | 0.07 |
Smoking (%) | 0.007 | |||
Current | 36.1 | 43.8 | 27.2 | |
Former | 36.9 | 28.5 | 46.5 | |
Never | 27.0 | 27.7 | 26.3 | |
Laboratory data | ||||
Hemoglobin (g/dL) | 12.9 ± 1.72 | 13.1 ± 1.62 | 12.6 ± 1.80 | 0.008 |
Peak creatine kinase (IU/L) | 2841 ± 2583 | 2871 ± 2460 | 2778 ± 2743 | 0.83 |
Albumin (g/dL) | 3.9 ± 0.4 | 4.0 ± 0.4 | 3.9 ± 0.4 | 0.15 |
High-sensitive CRP (mg/dL) | 0.76 ± 0.33 | 0.80 ± 1.19 | 0.73 ± 1.24 | 0.67 |
eGFR (mL/min/1.73 m2) | 61.5 ± 18.4 | 74.5 ± 11.5 | 46.5 ± 12.5 | 0.001 |
HbA1c (%) | 6.03 ± 1.17 | 6.02 ± 1.29 | 6.06 ± 1.07 | 0.87 |
Left ventricular ejection fraction (%) | 50.7 ± 13.3 | 53.4 ± 11.4 | 47.5 ± 14.7 | 0.001 |
Ankle-brachial index | 1.08 ± 0.12 | 1.09 ± 0.12 | 1.08 ± 0.13 | 0.68 |
Duration of hospital stay (days) | 26.8 ± 17.2 | 24.8 ± 14.4 | 29.2 ± 19.7 | 0.04 |
6-min walk distance (m) | 464.6 ± 101.1 | 470.3 ± 104.2 | 459.0 ± 97.8 | 0.43 |